secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNIVERSAL BIOSENSORS INC (—)
CIK:        0001279695
Form:       8-K
Filed at:   2024-04-11T23:59:59+00:00
Accession:  0001437749-24-011712
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Universal Biosensors launches A$10M underwritten entitlement offer at A$0.15/CDI with attaching options
--------------------------------------------------------------------------------

- Fully underwritten pro-rata non-renounceable offer of 1 new CDI per 3.47 existing at A$0.15, plus 1 option per CDI (A$0.20 exercise, 3-year term).
- Underwriter receives 13.85M options as fee; gross proceeds ~A$10M to fund growth, product development, operating losses, and Xprecia Prime sales after FDA approval.
- Stockholders approved increase in authorized common shares from 300M to 750M at April 10 special meeting.
- All four stockholder proposals passed: Underwriter Options, Placement CDIs, Placement Options, and Authorized Shares increase.
- Offer restricted to Australia/New Zealand resident holders; U.S. persons and other ineligible holders excluded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/ubi20240411_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-011712

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer